FI954072A - Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit - Google Patents

Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit Download PDF

Info

Publication number
FI954072A
FI954072A FI954072A FI954072A FI954072A FI 954072 A FI954072 A FI 954072A FI 954072 A FI954072 A FI 954072A FI 954072 A FI954072 A FI 954072A FI 954072 A FI954072 A FI 954072A
Authority
FI
Finland
Prior art keywords
aliphatically
diones
thia
quinoxaline
oxo
Prior art date
Application number
FI954072A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954072A0 (fi
Inventor
Robert Moretti
Kaspar Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI954072A0 publication Critical patent/FI954072A0/fi
Publication of FI954072A publication Critical patent/FI954072A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI954072A 1994-09-01 1995-08-30 Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit FI954072A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH268094 1994-09-01
CH40295 1995-02-09

Publications (2)

Publication Number Publication Date
FI954072A0 FI954072A0 (fi) 1995-08-30
FI954072A true FI954072A (fi) 1996-03-02

Family

ID=25684470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954072A FI954072A (fi) 1994-09-01 1995-08-30 Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit

Country Status (12)

Country Link
EP (1) EP0705835A1 (fr)
JP (1) JPH08109185A (fr)
KR (1) KR960010651A (fr)
CN (1) CN1133844A (fr)
AU (1) AU3028795A (fr)
BR (1) BR9503876A (fr)
CA (1) CA2157231A1 (fr)
FI (1) FI954072A (fr)
HU (1) HUT73436A (fr)
IL (1) IL115103A0 (fr)
NO (1) NO953420L (fr)
NZ (1) NZ272888A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9711274B (en) * 1996-12-16 1998-06-23 Warner Lambert Co Tricyclic quinoxaline derivatives as neuroprotective agents.
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
EP2489659B1 (fr) 2004-06-24 2017-12-13 Vertex Pharmaceuticals Incorporated Modulateurs de transporteurs de cassette de liaison a l´ATP
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
ES2790700T3 (es) 2005-12-28 2020-10-28 Vertex Pharma Composiciones farmacéuticas de la forma amorfa de N-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-dihidro-4-oxoquinolin-3-carboxamida
BRPI1011506B8 (pt) 2009-03-20 2021-05-25 Vertex Pharma processo para a fabricação de moduladores de regulador de condutância de transmembrana de fibrose cística
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CN104470518A (zh) 2012-02-27 2015-03-25 沃泰克斯药物股份有限公司 药物组合物及其施用
WO2016057730A1 (fr) 2014-10-07 2016-04-14 Strohmeier Mark Co-cristaux de modulateurs du régulateur de conductance transmembranaire de la mucoviscidose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
ATE404201T1 (de) * 1992-06-22 2008-08-15 Univ California Glycinrezeptorantagonisten und ihre verwendung
WO1994009000A1 (fr) * 1992-10-13 1994-04-28 Warner-Lambert Company Derives de quinoxalinedione utiles comme antagonistes d'acides amines excitateurs
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

Also Published As

Publication number Publication date
IL115103A0 (en) 1995-12-08
KR960010651A (ko) 1996-04-20
JPH08109185A (ja) 1996-04-30
NO953420L (no) 1996-03-04
AU3028795A (en) 1996-03-14
FI954072A0 (fi) 1995-08-30
CN1133844A (zh) 1996-10-23
NO953420D0 (no) 1995-08-31
BR9503876A (pt) 1996-09-17
HUT73436A (en) 1996-07-29
CA2157231A1 (fr) 1996-03-02
EP0705835A1 (fr) 1996-04-10
HU9502562D0 (en) 1995-10-30
NZ272888A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
FI102434B (fi) Kahden taajuuden antenni
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
FI954072A (fi) Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit
TR199500890A2 (tr) Bitki öldürücü maddeler olarak 4-fenoksikumarinler.
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
DE69709173T2 (de) Belastungswalzenanordnüng.
FI953549A0 (fi) Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DE59510943D1 (de) 2-Arylcyclopentan-1,3-dion-Derivate
ES1033200Y (es) Linterna - caramelo.
ES1034095Y (es) Celosia antivandalica.
FR2714950B3 (fr) Réducteur-variateur.
IT234659Y1 (it) Sottosella.
FR2720962B1 (fr) Baguetteuse.
FR2720961B1 (fr) Baguetteuse.
ES1034158Y (es) Arsonvalizador.
ES1035219Y (es) Chincheta-clip.
ES1033500Y (es) Caja-expositor.
FI943502A0 (fi) Anordning foer koppling av arbetsmaskin till drivanordning, saosom traktor
FI940063A0 (fi) Foerfarande foer foerevisning av landskap foer turister, resande m.fl.
FIU940078U0 (fi) Utrymme, saosom bastu av elementkonstruktion
NL1006012A1 (nl) Filter.
ES1033250Y (es) Nueva lapida.
ES1033877Y (es) Nueva caperuza-precinto.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed